You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,987,441

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,987,441 protect, and when does it expire?

Patent 8,987,441 protects XOFLUZA and is included in two NDAs.

This patent has thirty-two patent family members in twenty-three countries.

Summary for Patent: 8,987,441

Patent landscape, scope, and claims:

Title:	Substituted polycyclic carbamoyl pyridone derivative prodrug
Abstract:	The present invention provides a compound having antiviral effects, particularly having growth inhibitory activity on influenza viruses, a preferred example of the compound being a substituted 3-hydroxy-4-pyridone derivative prodrug having cap-dependent endonuclease inhibitory activity.
Inventor(s):	Takahashi; Chika (Toyonaka, JP), Mikamiyama; Hidenori (Toyonaka, JP), Akiyama; Toshiyuki (Toyonaka, JP), Tomita; Kenji (Toyonaka, JP), Taoda; Yoshiyuki (Toyonaka, JP), Kawai; Makoto (Toyonaka, JP), Anan; Kosuke (Toyonaka, JP), Miyagawa; Masayoshi (Toyonaka, JP), Suzuki; Naoyuki (Toyonaka, JP)
Assignee:	Shionogi & Co., Ltd. (Osaka, JP)
Application Number:	13/824,723
Patent Claim Types: see list of patent claims	Composition; Compound;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 8,987,441

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Genentech Inc	XOFLUZA	baloxavir marboxil	FOR SUSPENSION;ORAL	214410-001	Nov 23, 2020		RX	Yes	Yes	8,987,441	⤷ Subscribe	Y	Y			⤷ Subscribe
Genentech Inc	XOFLUZA	baloxavir marboxil	TABLET;ORAL	210854-001	Oct 24, 2018		DISCN	Yes	No	8,987,441	⤷ Subscribe	Y	Y			⤷ Subscribe
Genentech Inc	XOFLUZA	baloxavir marboxil	TABLET;ORAL	210854-002	Oct 24, 2018		RX	Yes	No	8,987,441	⤷ Subscribe	Y	Y			⤷ Subscribe
Genentech Inc	XOFLUZA	baloxavir marboxil	TABLET;ORAL	210854-003	Mar 18, 2021		RX	Yes	Yes	8,987,441	⤷ Subscribe	Y	Y			⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 8,987,441

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2010-213012	Sep 24, 2010

PCT Information
PCT Filed	September 21, 2011	PCT Application Number:	PCT/JP2011/071446
PCT Publication Date:	March 29, 2012	PCT Publication Number:	WO2012/039414

International Family Members for US Patent 8,987,441

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2620436	⤷ Subscribe	C02620436/01	Switzerland	⤷ Subscribe
European Patent Office	2620436	⤷ Subscribe	301093	Netherlands	⤷ Subscribe
European Patent Office	2620436	⤷ Subscribe	PA2021505	Lithuania	⤷ Subscribe
European Patent Office	2620436	⤷ Subscribe	122021000017	Germany	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.